{
    "id": "5c644c3de842deac67000018",
    "question": "Is cohesin linked to myeloid differentiation?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to analyze the relationship between cohesin and myeloid differentiation. According to Document [2], cohesin is essential for sister-chromatid cohesion, which is critical for proper chromosome segregation during cell division. Document [9] explains that hematopoietic stem cells go through a series of progressive restrictions to commit to either a myeloid or lymphoid fate. Document [12] describes the branching hierarchy of cells culminating in the many mature cell types that compose the blood and immune system, with myeloid progenitors giving rise to large numbers of all the different types of myeloid cells. Document [15] states that the BCR-ABL gene encodes a fusion protein that blocks myeloid differentiation, leading to excessive production of relatively normal blood cells. However, Document [13] explains that cohesin is required for proper chromosome segregation, and Document [14] describes the importance of cohesin in maintaining genome stability. Based on these documents, it appears that cohesin plays a role in maintaining genome stability, which is critical for proper cell division and differentiation. Therefore, cohesin is likely linked to myeloid differentiation, as proper cohesin function is necessary for the proper segregation of chromosomes during cell division, which is essential for the development of myeloid cells.\", \"answer_choice\": \"A\"}",
    "snippets": [
        {
            "id": "Cell_Biology_Alberts_4870",
            "title": "Cell_Biology_Alberts",
            "content": "Sister-chromatid cohesion depends on a large protein complex called cohesin, which is deposited at many locations along the length of each sister chromatid as the DNA is replicated in S phase. Two of the subunits of cohesin are members of a large family of proteins called SMC proteins (for Structural Maintenance of Chromosomes). Cohesin forms giant ringlike structures, and it has been proposed that these surround the two sister chromatids (Figure 17\u201319)."
        },
        {
            "id": "Cell_Biology_Alberts_4873",
            "title": "Cell_Biology_Alberts",
            "content": "Figure 17\u201319 Cohesin. Cohesin is a protein complex with four subunits. (a) Two subunits, smc1 and smc3, are coiled-coil proteins with an aTpase domain at one end; (B) two additional subunits, scc1 and scc3, connect the aTpase head domains, forming a ring structure that may encircle the sister chromatids as shown in (C). The aTpase domains are required for cohesin loading on the dna."
        },
        {
            "id": "Cell_Biology_Alberts_5074",
            "title": "Cell_Biology_Alberts",
            "content": "A. Which cells in Figure Q17\u20131 are in the G1, S, G2, and M phases of the cell cycle? Explain the basis for your answer. b. Sketch the sorting distributions you would expect for cells that were treated with inhibitors that block the cell cycle in the G1, S, or M phase. Explain your reasoning. Figure Q17\u20131 analysis of Hoechst 33342 fluorescence in a population of cells sorted in a flow cytometer (problem 17\u20138). 17\u20139 The yeast cohesin subunit Scc1, which is essential for sister-chromatid cohesion, can be artificially regulated for expression at any point in the cell cycle. If expression is turned on at the beginning of S phase, all the cells divide satisfactorily and survive. By contrast, if Scc1 expression is turned on only after S phase is completed, the cells fail to divide and they die, even though Scc1 accumulates in the nucleus and interacts efficiently with chromosomes. Why do you suppose that cohesin must be present during S phase for cells to divide normally?"
        },
        {
            "id": "Cell_Biology_Alberts_6837",
            "title": "Cell_Biology_Alberts",
            "content": "cohesin, cohesin complex Complex of proteins that holds sister chromatids together along their length before their separation. (Figure 17\u201319) coiled-coil Especially stable rodlike protein structure formed by two or more \u03b1 helices coiled around each other. (Figure 3\u20139) collagen Fibrous protein rich in glycine and proline that is a major component of the extracellular matrix in animals, conferring tensile strength. Exists in many forms: type I, the most common, is found in skin, tendon, and bone; type II is found in cartilage; type IV is present in basal laminae. (Figures 3\u201323 and 19\u201340) collagen fibril A higher-order collagen polymer of fibrillar collagens that assemble into thin structures (10\u2013300 nm in diameter) many hundreds of micrometers long in mature tissues. colony-stimulating factor (CSF) General name for numerous signal molecules that control differentiation of blood cells."
        },
        {
            "id": "Cell_Biology_Alberts_4884",
            "title": "Cell_Biology_Alberts",
            "content": "removal of cohesin molecules along the chromosome arms. As a result, when the cell reaches metaphase, the sister chromatids appear in the microscope as compact, rodlike structures that are joined tightly at their centromeric regions and only loosely along their arms."
        },
        {
            "id": "Cell_Biology_Alberts_5023",
            "title": "Cell_Biology_Alberts",
            "content": "Cohesins near the centromeres are protected from separase in meiosis I by a kinetochore-associated protein called shugoshin (from the Japanese word for \u201cguardian spirit\u201d). Shugoshin acts by recruiting a protein phosphatase that removes phosphates from centromeric cohesins. Cohesin phosphorylation is normally required for separase to cleave cohesin; thus, removal of this phosphorylation near the centromere prevents cohesin cleavage. Sister-chromatid pairs therefore remain linked through meiosis I, allowing their correct bi-orientation on the spindle in meiosis II. Shugoshin is inactivated after meiosis I. At the onset of anaphase II, APC/C activation triggers centromeric cohesin cleavage and sisterchromatid separation\u2014much as it does in mitosis. Following anaphase II, nuclear envelopes form around the chromosomes to produce four haploid nuclei, after which cytokinesis and other differentiation processes lead to the production of haploid gametes."
        },
        {
            "id": "InternalMed_Harrison_5345",
            "title": "InternalMed_Harrison",
            "content": "Although hematopoietic stem cells are generally thought to have the capacity to form all cells of the blood, it is becoming clear that individual stem cells may not be equal in their differentiation potential. That is, some stem cells are \u201cbiased\u201d to become mature cells of a particular type. In addition, the general concept of cells having a binary choice of lymphoid or myeloid differentiation is not entirely accurate. A cell population with limited myeloid (monocyte and granulocyte) and lymphoid potential is now added to the commitment steps stem cells may undergo."
        },
        {
            "id": "InternalMed_Harrison_5342",
            "title": "InternalMed_Harrison",
            "content": "types). For example, the myeloid progenitor can make all cells in the myeloid series but none in the lymphoid series. As common myeloid progenitors mature, they become precursors for either monocytes and granulocytes or erythrocytes and megakaryocytes, but not both. Some amount of reversibility of this process may exist early in the differentiation cascade, but that is lost beyond a distinct stage in normal physiologic conditions. With genetic interventions, however, blood cells, like other somatic cells, can be reprogrammed to become a variety of cell types."
        },
        {
            "id": "Cell_Biology_Alberts_5022",
            "title": "Cell_Biology_Alberts",
            "content": "Third, cohesion is removed in anaphase I only from chromosome arms and not from the regions near the centromeres, where the kinetochores are located. The loss of arm cohesion triggers homolog separation at the onset of anaphase I. This process depends on APC/C activation, which leads to securin destruction, separase activation, and cohesin cleavage along the arms (see Figure 17\u201338)."
        },
        {
            "id": "Cell_Biology_Alberts_6240",
            "title": "Cell_Biology_Alberts",
            "content": "Commitment is a Stepwise process Hematopoietic stem cells do not jump directly from a multipotent state into a commitment to just one pathway of differentiation; instead, they go through a series of progressive restrictions. The first step, usually, is commitment to either a myeloid or a lymphoid fate. This is thought to give rise to two kinds of progenitor cells, one capable of generating large numbers of all the different types of myeloid cells, and the other giving rise to large numbers of all the different types of lymphoid cells. Further steps give rise to progenitors committed to the production of just one cell type. The steps of commitment correlate with changes in the expression of specific transcription regulators, needed for the production of different subsets of blood cells. divisions of Committed progenitor Cells amplify the number of Specialized blood Cells"
        },
        {
            "id": "Cell_Biology_Alberts_6262",
            "title": "Cell_Biology_Alberts",
            "content": "Studies of hematopoiesis have been greatly aided by in vitro assays in which stem cells or committed progenitor cells form clonal colonies when cultured in a semisolid matrix. The progeny of stem cells seem to make their choices between alternative developmental pathways in a partly random manner. Cell death by apoptosis, controlled by the availability of CSFs, also plays a central part in regulating the numbers of mature differentiated blood cells."
        },
        {
            "id": "Pathology_Robbins_2898",
            "title": "Pathology_Robbins",
            "content": "http://ebooksmedicine.net In myeloproliferative neoplasms, the neoplastic clone continues to undergo terminal differentiation but exhibits increased or dysregulated growth. Commonly, these are associated with an increase in one or more of the formed elements (red cells, platelets, and/or granulocytes) in the peripheral blood. In myelodysplastic syndromes (MDS), terminal differentiation occurs but in a disordered and ineffective fashion, leading to the appearance of dysplastic marrow precursors and peripheral blood cytopenias. Although these three categories provide a useful starting point, the divisions between the myeloid neoplasms sometimes blur. Both MDS and myeloproliferative neoplasms often transform to AML, and some neoplasms have features of both myelodysplasia and myeloproliferative neoplasms. Because all myeloid neoplasms arise from early multipotent progenitors, the close relationship among these disorders is not surprising."
        },
        {
            "id": "InternalMed_Harrison_5341",
            "title": "InternalMed_Harrison",
            "content": "Hematopoietic stem cells sit at the base of a branching hierarchy of cells culminating in the many mature cell types that compose the blood and immune system (Fig. 89e-2). The maturation steps leading to terminally differentiated and functional blood cells take place both as a consequence of intrinsic changes in gene expression and niche-directed and cytokine-directed changes in the cells. Our knowledge of the details remains incomplete. As stem cells mature to progenitors, precursors, and, finally, mature effector cells, they undergo a series of functional changes. These include the obvious acquisition of functions defining mature blood cells, such as phagocytic capacity or hemoglobin synthesis. They also include the progressive loss of plasticity (i.e., the ability to become other cell types). For example, the myeloid progenitor can make all cells in the myeloid series but none in the lymphoid series. As common myeloid progenitors mature, they become precursors for either monocytes"
        },
        {
            "id": "Pathology_Robbins_2901",
            "title": "Pathology_Robbins",
            "content": "Most AMLs harbor mutations in genes encoding transcription factors that are required for normal myeloid cell differentiation. These mutations interfere with the differentiation of early myeloid cells, leading to the accumulation of myeloid precursors (blasts) in the marrow. Of particular interest is the (15;17) translocation in acute promyelocytic leukemia, which results in the fusion of the retinoic acid receptor \u03b1 (RARA) gene on chromosome 17 and the PML gene on chromosome 15. The chimeric gene produces a PML/RARA fusion protein that blocks myeloid differentiationat the promyelocyticstage, probablyinpart by inhibiting the function of normal retinoic acid receptors. Remarkably, pharmacologic doses of all-trans retinoic acid (ATRA), an analogue of vitamin A (Chapter 7), overcome this block and induce the neoplastic promyelocytes to differentiate into neutrophils rapidly. Because neutrophils die after an average life span of 6 hours, ATRA treatment rapidly clears the tumor. The effect"
        },
        {
            "id": "Pathology_Robbins_2903",
            "title": "Pathology_Robbins",
            "content": "Other work using mice has shown that the mutations in transcription factors found in AML are not sufficient to cause the disease. Putative collaborating mutations in several other tyrosine kinase genes and in the RAS gene have been detected. Sequencing of the AML genomes also has identified frequent mutations in genes that directly impact the epigenome, suggesting that epigenetic alterations have a central role in AML. For example, about 15% to 20% of AMLs are associated with mutations in isocitrate dehydrogenase (IDH). In such tumors, an \u201concometabolite\u201d synthesized by the mutated IDH protein blocks the function of enzymes that regulate the epigenome and interferes with myeloid cell differentiation (discussed in Chapter 6). Inhibitors of mutant IDH prevent the production of the oncometabolite and often produce remissions in this particular molecular subtype of AML."
        },
        {
            "id": "Pathology_Robbins_2919",
            "title": "Pathology_Robbins",
            "content": "As described in Chapter 6, the BCR-ABL gene encodes a fusion protein consisting of portions of BCR and the tyrosine kinase domain of ABL. Normal myeloid progenitors depend on signals generated by growth factors and their receptors for growth and survival. The growth factor dependence of CML progenitors is greatly decreased by constitutive signals generated by BCR-ABL that mimic the effects of growth factor receptor activation. Importantly, because BCR-ABL does not inhibit differentiation, the early disease course is marked by excessive production of relatively normal blood cells, particularly granulocytes and platelets. MORPHOLOGYTheperipheralbloodfindingsarehighlycharacteristic.Theleukocytecountiselevated,oftenexceeding100,000cells/\u00b5L. The circulating cells are predominantly neutrophils, metamyelocytes, and myelocytes ("
        },
        {
            "id": "InternalMed_Harrison_8372",
            "title": "InternalMed_Harrison",
            "content": "MDS is a clonal hematopoietic stem cell disorder characterized by disordered cell proliferation and impaired differentiation, resulting in cytopenias and risk of progression to leukemia. Both chromosomal and genetic instability have been implicated, and both are likely aging-related. Cytogenetic abnormalities are found in approximately one-half of patients, and some of the same specific lesions are also seen in frank leukemia; aneuploidy (chromosome loss or gain) is more frequent than translocations. More sensitive assays, such as comparative genomic hybridization and single nucleotide polymorphism arrays, reveal chromosomal abnormalities in a large proportion of patients with normal conventional cytogenetics. Accelerated telomere attrition may destabilize the genome in marrow failure and predispose to acquisition of chromosomal lesions. Cytogenetic abnormalities are not random (loss of all or part of 5, 7, and 20, trisomy of 8) and may be related to etiology (11q23 following"
        },
        {
            "id": "Pathology_Robbins_2897",
            "title": "Pathology_Robbins",
            "content": "MatureBcelltumorthatusuallymanifestswithadvanceddiseaseinvolvinglymphnodes,bonemarrow,andextranodalsitessuchasthegut Associatedwithan(11;14)translocationthatresultsinover-expressionofcyclinD1,aregulatorofcellcycleprogression MatureBcelltumorarisingatextranodalsitesinvolvedbychronicinflammationresultingfromautoimmunityorinfection(e.g.,H. pylori) UnusualBcelltumorconsistingmostlyofreactivelymphocytes,macrophages,andstromalcells MalignantRScellsmakeupaminorpartofthetumormass. Myeloid neoplasms arise from hematopoietic progenitors and typically give rise to proliferations that involve the bone marrow and replace normal marrow elements. There are three broad categories of myeloid neoplasia: \u2022 In acute myeloid leukemia (AML), the neoplastic cells are blocked at an early stage of myeloid cell development. Immature myeloid cells (blasts) accumulate in the marrow and replace normal elements, and frequently circulate in the peripheral blood. http://ebooksmedicine.net"
        },
        {
            "id": "InternalMed_Harrison_6181",
            "title": "InternalMed_Harrison",
            "content": "Only a small proportion of the cells within a tumor are capable of initiating colonies in vitro or forming tumors at high efficiency when injected into immunocompromised NOD/SCID mice. Acute and chronic myeloid leukemias (AML and CML) have a small population of cells (<1%) that have properties of stem cells, such as unlimited self-renewal and the capacity to cause leukemia when serially transplanted in mice. These cells have an undifferentiated phenotype (Thy1\u2212 CD34+CD38\u2013 and do not express other differentiation markers) and resemble normal stem cells in many ways, but are no longer under homeostatic control (Fig. 102e-7). Solid tumors may also contain a population of stem cells. Cancer stem cells, like their normal counterparts, have unlimited proliferative capacity and paradoxically traverse the cell cycle at a very slow rate; cancer growth occurs largely due to expansion of the stem cell pool, the unregulated proliferation of an amplifying population, and failure of apoptosis"
        },
        {
            "id": "InternalMed_Harrison_24766",
            "title": "InternalMed_Harrison",
            "content": "not all cell differentiation stages are shown. The abbreviations for PIDs are contained in boxes placed at corresponding stages of the pathway. CGD, chronic granulomatous diseases; GATA2, zinc finger transcription factor; LAD, leukocyte adhesion deficiencies; MSMD, Mendelian susceptibility to mycobacterial disease; SCN, severe congenital neutropenia; WHIM, warts, hypogammaglobulinemia, infections, and myelokathexis."
        },
        {
            "id": "InternalMed_Harrison_8470",
            "title": "InternalMed_Harrison",
            "content": "AML with minimal differentiation AML with maturation Acute panmyelosis with myelofibrosis Myeloid sarcoma Myeloid proliferations related to Down syndrome Transient abnormal myelopoiesis Myeloid leukemia associated with Down syndrome aFrom SH Swerdlow et al (eds): World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARC Press, 2008. bDiagnosis is AML regardless of blast count. myelodysplasia-related changes based in part on medical history of an antecedent MDS or myelodysplastic/myeloproliferative neoplasm. The clinical features likely contribute to the prognosis of AML and have therefore been included in the classification. Genetic Findings and Relevance to the WHO Classification The"
        },
        {
            "id": "InternalMed_Harrison_5344",
            "title": "InternalMed_Harrison",
            "content": "way through the differentiation process in a defined molecular program involving the sequential activation of particular sets of genes. For any particular cell type, the differentiation program is difficult to speed up. The time it takes for hematopoietic progenitors to become mature cells is ~10\u201314 days in humans, evident clinically by the interval between cytotoxic chemotherapy and blood count recovery in patients."
        },
        {
            "id": "InternalMed_Harrison_5340",
            "title": "InternalMed_Harrison",
            "content": "survival of stem cells, such as cyclin-dependent kinase inhibitors, transcription factors like Bmi-1, or microRNA-processing enzymes like Dicer, have little or different effects on progenitor cells. Hematopoietic stem cells have governing mechanisms that are distinct from the cells they generate."
        },
        {
            "id": "InternalMed_Harrison_8812",
            "title": "InternalMed_Harrison",
            "content": "Atypical chronic myeloid leukemia, BCR-ABL1 negative (aCML) is formally classified under the MDS/MPN category of myeloid malignancies and is characterized by left shifted granulocytosis and dysgranulopoiesis. The differential diagnosis of aCML includes chronic myeloid leukemia (CML), which is distinguished by the presence of BCR-ABL1; CNL, which is distinguished by the absence of dysgranulopoiesis and presence of CSF3R mutations; and chronic myelomonocytic leukemia, which is distinguished by the presence of monocytosis (absolute monocyte count >1 \u00d7 109/L). The WHO diagnostic criteria for aCML are listed in Table 135e-5 and include granulocytosis (WBC \u226513 \u00d7 109/L), neutrophilia with dysgranulopoiesis, \u226510% immature granulocytes, <20% peripheral blood myeloblasts, <10% peripheral blood monocytes, <2% basophils, and absence of otherwise specific mutations such as BCR-ABL1. The bone marrow is hypercellular with granulocyte proliferation and dysplasia with or without erythroid or"
        },
        {
            "id": "Cell_Biology_Alberts_5005",
            "title": "Cell_Biology_Alberts",
            "content": "Meiosis reduces the chromosome number by half using many of the same molecular machines and control systems that operate in mitosis. As in the mitotic cell cycle, the cell begins the meiotic program by duplicating its chromosomes in meiotic S phase, resulting in pairs of sister chromatids that are tightly linked along their entire lengths by cohesin complexes. Unlike mitosis, however, two successive rounds of chromosome segregation then occur (Figure 17\u201353). The first of these divisions (meiosis I) solves the problem, unique to meiosis, of segregating the homologs. The duplicated paternal and maternal homologs pair up alongside each other and become physically linked by the process of genetic recombination. These pairs of homologs, each containing a pair of sister chromatids, then line up on the first meiotic spindle. In the first meiotic anaphase, duplicated homo-logs rather than sister chromatids are pulled apart and segregated into the two daughter nuclei. Only in the second"
        },
        {
            "id": "Cell_Biology_Alberts_6937",
            "title": "Cell_Biology_Alberts",
            "content": "mechanosensitive channels Transmembrane ion channels that open in response to a mechanical stress on the lipid bilayer in which they are embedded. megakaryocyte Large myeloid cell with a multilobed nucleus that remains in the bone marrow when mature. Buds off platelets from long cytoplasmic processes. (Figures 22\u201329) meiosis I The first of two rounds of chromosome segregation following meiotic chromosome duplication; segregates the homologs, each composed of a tightly linked pair of sister chromatids. meiosis II The second of two rounds of chromosome segregation following meiotic chromosome duplication; segregates the sister chromatids of each homolog."
        },
        {
            "id": "InternalMed_Harrison_5356",
            "title": "InternalMed_Harrison",
            "content": "Some limited understanding of self-renewal exists and, intriguingly, implicates gene products that are associated with the chromatin state, a high-order organization of chromosomal DNA that influences transcription. These include members of the polycomb family, a group of zinc finger\u2013containing transcriptional regulators that interact with the chromatin structure, contributing to the accessibility of groups of genes for transcription. One member, Bmi-1, is important in enabling hematopoietic stem cell self-renewal through modification of cell cycle regulators such as the cyclin-dependent kinase inhibitors. In the absence of Bmi-1 or of the transcriptional regulator, Gfi-1, hematopoietic stem cells decline in number and function. In contrast, dysregulation of Bmi-1 has been associated with leukemia; it may promote leukemic stem cell self-renewal when it is overexpressed. Other transcription regulators have also been associated with self-renewal, particularly homeobox, or \u201chox,\u201d genes."
        },
        {
            "id": "Cell_Biology_Alberts_5020",
            "title": "Cell_Biology_Alberts",
            "content": "Figure 17\u201358 Comparison of chromosome behavior in meiosis I, meiosis II, and mitosis. Chromosomes behave similarly in mitosis and meiosis II, but they behave very differently in meiosis I. (a) In meiosis I, the two sister kinetochores are located side-by-side on each homolog and attach to microtubules from the same spindle pole. The proteolytic cleavage of cohesin along the sister-chromatid arms unglues the arms and resolves the crossovers, allowing the duplicated homologs to separate at anaphase I, while the residual cohesin at the centromeres keeps the sisters together. Cleavage of centromeric cohesin allows the sister chromatids to separate at anaphase II. (B) In mitosis, by contrast, the two sister kinetochores attach to microtubules from different spindle poles, and the two sister chromatids come apart at the start of anaphase and segregate into separate daughter nuclei."
        },
        {
            "id": "Histology_Ross_1438",
            "title": "Histology_Ross",
            "content": "A hemopoietic stem cell (HSC) in the bone marrow gives rise to multiple colonies of progenitor stem cells. In the bone marrow, descendants of the HSC differentiate into two major colonies of multipotential progenitor cells: The common myeloid progenitor (CMP) cells and the common lymphoid progenitor (CLP) cells. Ultimately, common myeloid progenitor (CMP) cells which were previously called colony-forming units\u2013granulocyte, erythrocyte, monocyte, megakaryocyte (CFU-GEMM), differentiate into specific lineage-restricted progenitors (Table 10.3). These include the following."
        },
        {
            "id": "InternalMed_Harrison_6148",
            "title": "InternalMed_Harrison",
            "content": "of APL cells has improved treatment of these patients but also has led to a novel treatment toxicity when newly differentiated tumor cells infiltrate the lungs. However, ATRA represents a treatment paradigm for the reversal of epigenetic changes in cancer. For other leukemia-associated fusion proteins, such as acute myeloid leukemia (AML)-eight-twentyone (ETO) and the MLL fusion proteins seen in AML and acute lymphocytic leukemia, no ligand is known. Therefore, efforts are ongoing to determine the structural basis for interactions between translocation fusion proteins and chromatin-remodeling proteins and to use this information to rationally design small molecules that will disrupt specific protein-protein associations, although this has proven to be technically difficult. Drugs that block the enzymatic activity of HDAC are"
        },
        {
            "id": "Histology_Ross_486",
            "title": "Histology_Ross",
            "content": "\u0081 Anaphase (Fig. 3.15) begins at the initial separation of sister chromatids. This separation occurs when the cohesins that have been holding the chromatids together break down. The chromatids then begin to separate and are pulled to opposite poles of the cell by the molecular motors (dyneins) sliding along the kinetochore micro-tubules toward the MTOC."
        },
        {
            "id": "Cell_Biology_Alberts_5017",
            "title": "Cell_Biology_Alberts",
            "content": "Each homolog is organized around a protein axial core, and the synaptonemal axes are linked by rod-shaped transverse filaments. The axial core of each homolog also interacts with the cohesin complexes axial cores that hold the sister chromatids together of the (see Figure 9\u201335). (modified from homologs k. nasmyth, Annu. Rev. Genet. 35:673\u2013 745, 2001.) cohesin chromatin loops of sister chromatids of one homolog along their entire lengths (see Figure 9\u201335). The pachytene stage can persist for days or longer, until desynapsis begins at diplotene with the disassembly of the synaptonemal complexes and the concomitant condensation and shortening of the chromosomes. It is only at this stage, after the complexes have disassembled, that the individual crossover events between nonsister chromatids can be seen as inter-homolog connections called chiasmata (singular chiasma), which now play a crucial part in holding the compact homologs together (Figure 17\u201357). The homologs are now ready to begin"
        }
    ],
    "scores": [
        0.03728542115009259,
        0.0348022460347486,
        0.03262497113500201,
        0.02941364953171502,
        0.02814360984209056,
        0.028030604537073886,
        0.02704019809282967,
        0.026335973389525355,
        0.025227541254059516,
        0.025227534856558872,
        0.02468004403968663,
        0.02277278809613017,
        0.02260761460761461,
        0.02170273489291894,
        0.019665218592216503,
        0.019369669694696782,
        0.018354803401532373,
        0.018245327106463937,
        0.017934014792653538,
        0.01789280293953191,
        0.017733835530445698,
        0.017720530835284937,
        0.016986811926605505,
        0.01660465757199945,
        0.016437992974083646,
        0.016280566280566282,
        0.016167318919612497,
        0.016103059581320453,
        0.016095934333718098,
        0.01596159615961596,
        0.01579520697167756,
        0.015180265654648957
    ]
}